Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,read with applicable circulars issued by Securities and Exchange Board of India, BSE ....
INNOVACAP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Innova Captab has submitted its Annual Secretarial Compliance Report for FY25, issued by Practicing Company Secretary Jaspreet Singh Dhawan. The report confirms the company has complied with all applicable SEBI regulations, including listing obligations, insider trading rules, related party transaction approvals, and disclosure requirements under Regulation 30. The company identified two material subsidiaries — Univentis Medicare Limited and Sharon Bio-Medicine Limited — and has reported that no directors are disqualified under Section 164 of the Companies Act. There was a change in statutory auditor at one material subsidiary (Sharon Bio-Medicine), but the company complied with the required Master Circular provisions. No actions were taken against the company or its promoters/directors by SEBI or the stock exchanges during the review period, and no additional non-compliance was observed.
This is a routine annual compliance filing with a clean report — no penalties, no disqualifications, and no non-compliance flags, which signals good corporate governance but is unlikely to move the stock price.